ArticleThe Lancet regional health. Western Pacific2023

Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study.

Jiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.